Stock Transactions

12 Months Ended

Dec. 31, 2021

Equity [Abstract]

Stock Transactions

Note 12 – Stock Transactions

Common Stock Issued

The Company sold 6,526,786 common shares valued at $1.75 per share to various investors for proceeds totaling $11,421,875 during the year ended December 31, 2021. The Company received $100,000 of the proceeds in the first quarter of 2022 for which a receivable was recorded at December 31, 2021. The Company paid the placement agent $1,013,500 in cash and issued 1,759,785 warrants.

The Company sold 1,000,000 common shares valued at $3.00 per share to an investor for proceeds of $3,000,000 on September 30, 2021. 

The Company sold 1,250 common shares valued at $1.25 per share to a director for proceeds of $1,562 on September 28, 2021.

In connection with the convertible notes payable (see Note 10 above) various noteholders converted $2,395,000 of principal balance to 1,365,501 shares of common stock during the year ended December 31, 2021. The stock issued was determined based on the terms of the convertible notes.

During the year ended December 31, 2021, various shareholders exercised warrants in exchange for 106,578 common shares for proceeds of $153,424.

On December 14, 2021, a shareholder exercised options in exchange for 89,421 common shares valued at $2.00 per share for proceeds of $178,842.

In connection with the acquisition of Procare the Company issued 607,229 common shares valued at $4.00 per share and 151,807 common shares valued at $446,018 to the shareholders of Procare on October 1, 2021.

In connection with the acquisition of AHA the Company issued 14,218,241 common shares valued at $2.06 per share to the shareholders of AHA on February 25, 2021.

In connection with the acquisition of AHP the Company issued 19,000,000 common shares valued at $2.06 per share to the shareholders of AHP on February 25, 2021.

In connection with the AHA and AHP acquisitions, the Company issued 750,000 common shares valued at $2.06 per share for consulting services on February 25, 2021.

On January 28, 2021, the Company issued 182,567 common shares to officers and employees for deferred salaries and bonuses and reimbursed expenses, including 153,606 common shares issued to directors and officers, valued at $.65 per share.

On January 28, 2021, the Company issued 46,154 common shares valued at $.65 per share to a former officer for payment of a note balance of $30,000.

The Company issued 225,820 restricted common shares to employees for salaries on June 30, 2020, valued at $361,312. On September 28, 2020, 23,276 of these shares issued to an employee, valued at $33,750 were cancelled in connection with a separation agreement.

The Company issued 228,346 common shares to an employee in connection with a separation agreement on July 12, 2020, valued at $290,000.

On August 12, 2020, the Company sold 190,476 restricted shares of common stock valued at $0.63 per share to 5 directors and an investor for proceeds of $120,000.

The Company issued 12,000 common shares to an employee in connection with a separation agreement on September 11, 2020, valued at $15,000.